Watson W. Mark
- SEC CIK
- 0001612372
In the past year, 2 open-market purchase filings worth $14.7K and no sales.
Current role at each company
- VXRT Vaxart, Inc.Directoras of Jul 17, 2026
- BDSI Biodelivery Sciences International IncDirectoras of Mar 22, 2022
- SYKE Sykes Enterprises IncDirectoras of Aug 27, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $14.7K
- 2 filings
- Sold
- –
- 0 filings
- Net
- +$14.7K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Watson W. Mark as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
VXRT Vaxart, Inc.
Director5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 26, 2026 (view filing) | May 22 | 4 days | Watson W. MarkDirector | PPurchase | +10.0K | $0.65 | +$6.50K | +8.1%134.1K after | |
| Dec 5, 2025 (view filing)5:46 PM ET | Nov 17 | 18 daysLate | Watson W. MarkDirector | PPurchase | +20.0K | $0.4093 | +$8.19K | +19.2%124.1K after | 2 lots |
| Jul 31, 2025 (view filing)8:38 PM ET | Jul 29 | 2 days | Watson W. MarkDirector | PPurchase | +10.0K | $0.405 | +$4.05K | +10.6%104.1K after | |
| Jun 20, 2024 (view filing) | Jun 18 | 2 days | Watson W. MarkDirector | PPurchase | +20.0K | $0.68 | +$13.6K | +34.4%78.1K after | |
| Dec 28, 2022 (view filing) | Dec 28 | Same day | Watson W. MarkDirector | PPurchase | +20.0K | $0.76 | +$15.2K | New position20.0K after |